Afficher la couverture 'Non Alcoholic Fatty Liver Disease (NAFLD): Development of a relevant in vitromodel. Non Alcoholic Fatty Liver Disease (NAFLD): Development of a relevant in vitromodel: Non Alcoholic Fatty Liver Disease (NAFLD): Development of a relevant in vitro model. : Maladie du foie gras non alcoolique (NAFLD) : Développement d'un modèle in vitro pertinent | Merheb, Camil' en grand format
/5

0 avis

Non Alcoholic Fatty Liver Disease (NAFLD): Development of a relevant in vitromodel. Non Alcoholic Fatty Liver Disease (NAFLD): Development of a relevant in vitromodel: Non Alcoholic Fatty Liver Disease (NAFLD): Development of a relevant in vitro model. : Maladie du foie gras non alcoolique (NAFLD) : Développement d'un modèle in vitro pertinent

Archive ouverte

Merheb, Camil | da Silva, Franck | Rathar, Raissa | Salvador, Lorine | Briolotti, Philippe | Gerbal-Chaloin, Sabine | Daujat-Chavanieu, Martine

Edité par CCSD -

International audience

Consulter en ligne

Suggestions

Du même auteur

Non Alcoholic Fatty Liver Disease (NAFLD): Development of a relevant in vitro model. Maladie du foie gras non alcoolique (NAFLD) : Développement d'un modèle in vitro pertinent

Archive ouverte | Merheb, Camil | CCSD

International audience

Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling

Archive ouverte | Briolotti, Philippe | CCSD

SUPPLEMENTARY DATA are available online at http://toxsci.oxfordjournals.org/. International audience. Cytochrome P450 (CYP) expression and activity are not homogeneous in the liver lobules. Indeed, CYPs are main...

Omega-3 Fatty Acids, Furan Fatty Acids, and Hydroxy Fatty Acid Esters: Dietary Bioactive Lipids with Potential Benefits for MAFLD and Liver Health

Archive ouverte | Merheb, Camil | CCSD

International audience. Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common form of chronic liver disease, for which only resmetirom has recently received FDA approval. Prevention is cruc...

Chargement des enrichissements...